Clinical trial
Combating Diagnostic Wandering and Impasse for Cystic Fibrosis: Assessment of Patients Not Concluded After Neonatal Screening of Cystic Fibrosis
NCT05654480 is registered in ClinicalTrials.gov with Societe Francaise de la Mucoviscidose as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Combating Diagnostic Wandering and Impasse for Cystic Fibrosis: Assessment of Patients Not Concluded After Neonatal Screening of Cystic Fibrosis
- Lead sponsor
- Societe Francaise de la Mucoviscidose
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 2, 2023
- Completion date
- December 31, 2024
- Enrollment
- 400 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.